A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment

This study has been completed.

Study NCT00240695 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: October 14, 2005 Last Updated: March 17, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2004
Estimated Primary Completion Date:	No date given